Aaron Gajadhar, PhD
Director, Strategic Applications
at Seer
Aaron Gajadhar received his doctorate in medical biophysics at the University of Toronto. Following his graduate training, he completed a postdoctoral fellowship at MIT with Forest White at the Koch Institute for Integrated Cancer Research. In 2015, Gajadhar joined Merrimack Pharmaceuticals in Cambridge, where he worked as a senior scientist in early discovery. Gajadhar joined Thermo Fisher Scientific in San Jose in 2017 and was involved in developing new LC-MS technologies for the proteomics market. Since 2021, Gajadhar worked at Seer in roles spanning program management for proof-of-principle and collaborations, software product management, and, more recently, overseeing the strategic applications group to explore novel uses of Seer’s Proteograph Product Suite.
Got a Question for Aaron Gajadhar, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly.